Artal Group S.A. Mei Pharma, Inc. Transaction History

Artal Group S.A.

  • $1.58 Billion
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 13, 2021
BUY
$2.6 - $3.65 $624,000 - $876,000
240,000 Added 31.58%
1,000,000 $2.85 Million
Q3 2020

Nov 13, 2020
BUY
$2.46 - $4.27 $113,160 - $196,419
46,000 Added 6.44%
760,000 $2.37 Million
Q2 2020

Aug 14, 2020
BUY
$1.45 - $4.3 $1.04 Million - $3.07 Million
714,000 New
714,000 $2.95 Million

Others Institutions Holding MEIP

# of Institutions
1
Shares Held
2K
Call Options Held
0
Put Options Held
0
View Full List

About MEI Pharma, Inc.

MEIP Quotes by TradingView
  • Ticker MEIP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 133,261,000
  • Market Cap $366M
  • Description
  • MEI Pharma, Inc., a late-stage pharmaceutical company, focuses on the development and commercialization of various therapies for the treatment of cancer. The company develops Zandelisib, an oral phosphatidylinositol 3-kinase delta inhibitor that is in Phase III clinical trial for the treatment of patients with relapsed/refractory follicular lymp...
More about MEIP
Track This Portfolio

Track Artal Group S.A. Portfolio

Follow Artal Group S.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Artal Group S.A., based on Form 13F filings with the SEC.

News

Stay updated on Artal Group S.A. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email